Published in Arch Neurol on October 01, 1999
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol (2008) 3.99
CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology (2008) 2.43
Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology (2013) 2.26
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain (2009) 1.93
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs (2010) 1.72
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A (2010) 1.68
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain (2014) 1.54
Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology (2008) 1.48
Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging (2009) 1.46
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry (2010) 1.43
Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol (2012) 1.42
Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol (2001) 1.35
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain (2012) 1.26
Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology (2003) 1.25
The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev (2008) 1.25
Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.23
Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol (2009) 1.21
The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol (2012) 1.18
Objective metamemory testing captures awareness of deficit in Alzheimer's disease. Cortex (2007) 1.17
Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology (2005) 1.14
Neuropsychological function in nondemented carriers of presenilin-1 mutations. Neurology (2005) 1.13
Distinguishing Alzheimer's disease from other major forms of dementia. Expert Rev Neurother (2011) 1.12
With or without FUS, it is the anatomy that dictates the dementia phenotype. Brain (2009) 1.12
Dissociations in hippocampal and frontal contributions to episodic memory performance. Neuropsychology (2005) 1.09
Cholinergic modulation of a specific memory function of prefrontal cortex. Nat Neurosci (2011) 1.00
Nonamnestic presentations of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen (2012) 0.99
Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology (2014) 0.99
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimers Res Ther (2013) 0.99
Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry (2002) 0.95
Alzheimer's disease: a clinical practice-oriented review. Front Neurol (2012) 0.95
Clinicopathologic correlation in PGRN mutations. Neurology (2007) 0.95
Isolated executive impairment and associated frontal neuropathology. Dement Geriatr Cogn Disord (2004) 0.94
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain (2015) 0.94
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol (2012) 0.94
Executive dysfunction in Alzheimer disease. Arch Neurol (2004) 0.94
Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging (2011) 0.90
Verbal fluency predicts mortality in Alzheimer disease. Cogn Behav Neurol (2006) 0.89
Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors. Alzheimer Dis Assoc Disord (2013) 0.89
Clinico-pathological correlations of the most common neurodegenerative dementias. Front Neurol (2012) 0.86
Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2012) 0.86
Evolution of the diagnostic criteria for degenerative and cognitive disorders. Curr Opin Neurol (2011) 0.86
Amyloid imaging in atypical presentations of Alzheimer's disease. Curr Neurol Neurosci Rep (2013) 0.85
Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia. Curr Neuropharmacol (2006) 0.83
Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes. Int Rev Psychiatry (2013) 0.83
Alzheimer Disease. Continuum (Minneap Minn) (2016) 0.83
An exploration of cognitive subgroups in Alzheimer's disease. J Int Neuropsychol Soc (2009) 0.82
Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis. J Neurol (2015) 0.81
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry (2007) 0.81
Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease. Arch Neurol (2009) 0.80
The usefulness of biological and neuroimaging markers for the diagnosis of early-onset Alzheimer's disease. Int J Alzheimers Dis (2011) 0.80
Neuroanatomical profiles of personality change in frontotemporal lobar degeneration. Br J Psychiatry (2011) 0.80
Frontotemporal dementia and primary progressive aphasia, a review. Neuropsychiatr Dis Treat (2014) 0.80
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options. Neurodegener Dis Manag (2011) 0.80
Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2013) 0.80
Frontotemporal dementia: diagnosis, deficits and management. Neurodegener Dis Manag (2014) 0.79
Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database. PLoS One (2013) 0.79
Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses. Curr Alzheimer Res (2014) 0.79
Biomarkers to identify the pathological basis for frontotemporal lobar degeneration. J Mol Neurosci (2011) 0.78
Patient care and management of frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 0.78
Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation. Brain Pathol (2013) 0.78
Frequency of the apolipoprotein E ε4 allele in a memory clinic cohort in Beijing: a naturalistic descriptive study. PLoS One (2014) 0.78
Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI. Brain Imaging Behav (2012) 0.78
Neuroimaging in dementia. Semin Neurol (2008) 0.78
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease. JAMA Neurol (2017) 0.77
Dysexecutive syndrome in amnesic mild cognitive impairment: a multicenter study. BMC Neurol (2016) 0.77
Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology (2016) 0.77
Comparing the Neuropsychiatric Profile of Patients with Alzheimer Disease Who Present Spared versus Impaired Executive Functioning. Curr Gerontol Geriatr Res (2011) 0.76
Biomarkers in frontotemporal lobar degeneration. Curr Opin Neurol (2010) 0.76
Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease. Neurobiol Aging (2015) 0.76
Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study. Neurol Sci (2015) 0.76
Early-Onset Alzheimer Disease. Neurol Clin (2017) 0.75
Topography, histology, and seminology in dementia. Arch Neurol (2000) 0.75
Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome. Alzheimers Dement (Amst) (2016) 0.75
Approach to atypical Alzheimer's disease and case studies of the major subtypes. CNS Spectr (2017) 0.75
Alzheimer Disease: Scientific Breakthroughs and Translational Challenges. Mayo Clin Proc (2017) 0.75
Agreement among neuropsychological and behavioral data and PiB findings in diagnosing Frontotemporal Dementia. J Clin Neurosci (2017) 0.75
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging (1997) 5.66
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol (1989) 4.21
Crystal structure of a small heat-shock protein. Nature (1998) 4.07
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science (1989) 3.90
Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg (1999) 3.81
In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res (1991) 3.45
Alternatives to randomization in surgical studies. J Heart Valve Dis (1992) 3.34
Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res (1996) 3.18
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A (1997) 2.99
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology (1991) 2.77
Measurement of free electrophoretic mobility and retardation coefficient of protein-sodium dodecyl sulfate complexes by gel electrophoresis. A method to validate molecular weight estimates. J Biol Chem (1972) 2.73
Prosthetic valvular endocarditis. A 12-year review. Circulation (1973) 2.71
Structure-based assignment of the biochemical function of a hypothetical protein: a test case of structural genomics. Proc Natl Acad Sci U S A (1998) 2.70
Mitral replacement. Review of six years' experience. J Thorac Cardiovasc Surg (1967) 2.70
Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci (1985) 2.66
Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg (1997) 2.66
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
The Madurai Intraocular Lens Study. II: Clinical outcomes. Am J Ophthalmol (1998) 2.46
Synaptic proteins. Characterization of tubulin and actin and identification of a distinct postsynaptic density polypeptide. J Cell Biol (1978) 2.44
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res (1990) 2.26
Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem (1995) 2.24
Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J Am Geriatr Soc (1996) 2.23
Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res (1984) 2.21
Crystal structure of a fibrillarin homologue from Methanococcus jannaschii, a hyperthermophile, at 1.6 A resolution. EMBO J (2000) 2.20
Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol (2007) 2.17
Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature (1989) 2.17
Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res (1989) 2.12
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology (2008) 2.11
Risk of human immunodeficiency virus in surgeons, anesthesiologists, and medical students. Anesth Analg (1992) 2.03
Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol (2008) 1.99
Anterior pulmonary translocation for repair of truncus arteriosus with interrupted arch. Ann Thorac Surg (1995) 1.99
Red blood cell survival in patients with aortic valvular disease and ball-valve prostheses. Circulation (1965) 1.98
Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem (1995) 1.89
Aortic valve replacement. A review of six years' experience with the ball-valve prosthesis. Ann Thorac Surg (1968) 1.87
The analysis and presentation of surgical results by actuarial methods. J Surg Res (1974) 1.85
Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. Biochim Biophys Acta (1971) 1.84
Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci Lett (1986) 1.83
Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol Dis (1998) 1.81
Delayed neurological sequelae of electrical injuries. Neurology (1968) 1.81
Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene (2007) 1.79
Isolation of postsynaptic densities from rat brain. J Cell Biol (1974) 1.77
Auditory brain-stem responses in brain death. Brain (1976) 1.75
Phonocardiographic diagnosis of aortic ball variance. Circulation (1968) 1.73
Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J Neurochem (1999) 1.71
Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science (1989) 1.69
Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur J Neurosci (2001) 1.68
Aortico-left ventricular tunnel: a clinical review and new surgical classification. Ann Thorac Surg (1988) 1.66
Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br (1995) 1.65
Crystal structure of an intracellular protease from Pyrococcus horikoshii at 2-A resolution. Proc Natl Acad Sci U S A (2000) 1.65
Auditory brain stem responses in neurological disease. Arch Neurol (1975) 1.64
Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature (1984) 1.63
Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience (2004) 1.63
Isolation and structural studies on synaptic complexes from rat brain. J Cell Biol (1972) 1.63
BeF(3)(-) acts as a phosphate analog in proteins phosphorylated on aspartate: structure of a BeF(3)(-) complex with phosphoserine phosphatase. Proc Natl Acad Sci U S A (2001) 1.62
Temporal and speech processing deficits in auditory neuropathy. Neuroreport (1999) 1.60
Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus. Neuroscience (2005) 1.60
Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J Med Genet (2003) 1.60
Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol (2002) 1.58
Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav Neurosci (1998) 1.57
Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol (1991) 1.56
The prognosis of patients with coronary artery disease after coronary bypass operations. Time-related progress of 532 patients with disabling angina pectoris. Circulation (1974) 1.56
Valve repair for aortic insufficiency: surgical classification and techniques. Eur J Cardiothorac Surg (1997) 1.56
Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport (1991) 1.55
Tricuspid replacement for acquired valve disease. Surg Gynecol Obstet (1966) 1.54
Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis (2001) 1.54
Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochemistry (2001) 1.54
Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology (1999) 1.52
Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res (1983) 1.51
Development of auditory function in newborn infants revealed by auditory brainstem potentials. Pediatrics (1977) 1.51
Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet (1995) 1.51
Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Res (1981) 1.50
A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience (1995) 1.50
Baclofen selectively inhibits excitatory synaptic transmission in the hippocampus. Brain Res (1981) 1.50
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49
Age-related marrow conversion in the proximal metaphysis of the femur: evaluation with T1-weighted MR imaging. Radiology (1998) 1.47
Aortic valve replacement in elderly patients: influence of concomitant coronary grafting on late survival. Ann Thorac Surg (1996) 1.47
Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience (2000) 1.47
Long-term survival after postinfarction bypass operation: early versus late operation. Ann Thorac Surg (1989) 1.46
Do cerebral potentials to magnetic stimulation of paraspinal muscles reflect changes in palpable muscle spasm, low back pain, and activity scores? J Manipulative Physiol Ther (2000) 1.46
Plasticity of hippocampal circuitry in Alzheimer's disease. Science (1985) 1.46
RECENT EXPERIENCES WITH THROMBOPHLEBITIS OF THE LOWER EXTREMITY AND PULMONARY EMBOLISM: THE VALUE OF VENOGRAPHY AS A DIAGNOSTIC AID. Ann Surg (1942) 1.45
Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br (1995) 1.45
Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci (1997) 1.45
Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res (1980) 1.44
Microlithographic determination of axonal/dendritic polarity in cultured hippocampal neurons. J Neurosci Methods (1998) 1.44
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas. Neurology (2006) 1.44
Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect Immun (1997) 1.44
Coarctation repair: modification of end-to-end anastomosis with subclavian flap angioplasty. Ann Thorac Surg (1998) 1.43
Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem (2001) 1.43
Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res (1998) 1.42
Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature (1978) 1.42
DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci (1996) 1.41
An internalized double-J catheter for percutaneous transgastric cystogastrostomy. AJR Am J Roentgenol (1989) 1.40
Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature (1988) 1.40
Exercise and time-dependent benefits to learning and memory. Neuroscience (2010) 1.39
Crystal structure of phosphoserine phosphatase from Methanococcus jannaschii, a hyperthermophile, at 1.8 A resolution. Structure (2001) 1.39